The following valve and structural heart repairs are commercially available. For information on investigational structural heart procedures, please see our research page.
If you have aortic valve stenosis and are unable to withstand open heart surgery, you may be eligible for a procedure called transcatheter aortic valve replacement (TAVR). TAVR is valve replacement without open-heart surgery. It is also called catheter-based or percutaneous aortic valve replacement. A highly-trained cardiologist inserts a thin tube, called a catheter, into a vessel in your leg. That catheter carries a new compressed heart valve to your heart, where it will replace your own aortic valve.
Though TAVR was only recently approved by the FDA for certain patients, our center already has over five years of experience. We were the only hospital in Utah to participate in the procedure’s research and development. We were also the first in Utah to perform the procedure commercially.
The MitraClip device is now FDA approved for patients with worsening mitral valve regurgitation whose risk is too high for surgery.
MitraClip is the first catheter-based mitral valve repair therapy available in the United States. The device is placed via a catheter from the femoral vein and does not require a chest incision, use of a heart-lung machine, or stopping of the heart.
Our center participated in the clinical trials that evaluated this device, and we continue to evaluate its use in other types of patients with mitral regurgitation.
If you have atrial fibrillation, you may be eligible for a catheter-based procedure called the Watchman left atrial appendage closure, or “the Watchman procedure”. This procedure can reduce your risk of stroke and eliminate the need to take blood thinning medications.
In this procedure, a highly trained cardiologist uses a catheter to implant a small device in your heart. This device seals off your left atrial appendage, a windsock-shaped pouch high in the left atrium. This can reduce your risk of stroke and may eliminate your need for blood thinning medications.
Atrial septal defects (ASD) and patent foramen ovale (PFO) are holes between the two upper chambers of the heart. If you have clinical symptoms, your doctor may recommend closure of the hole. Our program uses a procedure where a catheter guides a flexible device through a blood vessel into your heart. The flexible device is positioned inside the defect and expanded to close off the opening.
A ventricular septal defect (VSD) is a hole in the wall between the lower chambers of the heart, also called the right and left ventricles. VSDs may be present from birth or may develop as a complication of a heart attack. VSDs are associated with abnormal blood flow, and if large, may be associated with shortness of breath. Large VSDs may also lead to a dangerous and potentially fatal elevation of blood pressure in the lungs known as pulmonary hypertension. Your doctor may recommend closing your VSD with a catheter-based procedure.
Valve replacement surgery is common, safe, and effective in the United States. However, on rare occasion the new surgically placed valve may separate from the heart tissue where it is sewn in place. This separation results in a "paravalvular" gap between the surgically placed valve and your own tissue. Blood flow through this defect may cause shortness of breath and blood cell destruction or anemia. Doctors treat these defects with surgery or with catheter-based devices.
Hypertrophic cardiomyopathy is an inherited condition where the septum, which separates the right and left ventricles, becomes thick and obstructs blood flow out of the heart. The small area of the septum that obstructs blood flow may be restored to normal thickness with a catheter-based procedure called septal ablation or with heart surgery.